Bumper Offer - Urjas oil Just @ Rs. 1
Lipicure CF 10 Capsule IR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Lipicure CF 10 Capsule IR is used -
Moderate
Mild
Common
Is the use of Lipicure CF 10 Capsule IR safe for pregnant women?
The effects of Lipicure CF on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Lipicure CF 10 Capsule IR safe during breastfeeding?
Information about safety of Lipicure CF for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Lipicure CF 10 Capsule IR on the Kidneys?
Kidney can be affected by Lipicure CF. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Lipicure CF 10 Capsule IR on the Liver?
The liver can be affected by Lipicure CF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Lipicure CF only after medical advice.
What is the effect of Lipicure CF 10 Capsule IR on the Heart?
You may experience side effects on your heart after taking Lipicure CF. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Lipicure CF 10 Capsule IR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lipicure CF 10 Capsule IR unless your doctor advises you to do so -
Is this Lipicure CF 10 Capsule IR habit forming or addictive?
Lipicure CF 10 Capsule IR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Lipicure CF 10 Capsule IR since it does not cause drowsiness.
Is it safe?
Lipicure CF 10 Capsule IR should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Lipicure CF 10 Capsule IR in mental disorders is not effective.
Interaction between Food and Lipicure CF 10 Capsule IR
Lipicure CF 10 Capsule IR may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Lipicure CF 10 Capsule IR
Due to lack of research, there is no information about the side effects of taking Lipicure CF 10 Capsule IR with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552